Leveraging Biosimulation to Inform Optimal Use of COVID-19 Vaccines White Paper Leveraging Biosimulation to Inform Optimal Use of COVID-19 Vaccines Certara2021 年 2 月 3 日
BaseCase Interactive for Medical Affairs Brochure BaseCase Interactive for Medical Affairs Certara2021 年 1 月 28 日
Getting Real with RWE Press Coverage Getting Real with RWE By Taren Grom Real-world evidence, important for regulatory decision-making, is beginning to touch all areas…Certara2020 年 11 月 20 日
Galderma Achieves FDA Approval of AKLIEF® (trifarotene) Case Study Galderma AKLIEF®(曲法罗汀)获得了 FDA 批准 In October 2019, Galderma announced that the U.S. FDA approved AKLIEF® (trifarotene) Cream, 0.005% for the…Certara2020 年 11 月 9 日
The Effects of COVID-19 on Stakeholder Engagement & Value Communication: Preparing for the New Normal White Paper COVID-19 对利益相关者参与和价值传播的影响:准备迎接 New Normal Certara2020 年 10 月 28 日
SNDS: Strengths, Limitations and Perspectives for the Largest and Richest Real-World Database in EU On-Demand Webinar SNDS: Strengths, Limitations and Perspectives for the Largest and Richest Real-World Database in EU In this webinar, our experts provided an overview of the SNDS and the key working…Certara2020 年 10 月 20 日
New Pinnacle 21 Community Validation Engine: FDA (1907.2) Announcement New Pinnacle 21 Community Validation Engine: FDA (1907.2) In August 2020, we released our new Pinnacle 21 validation engine “FDA (1907.2)” for preparing…Certara2020 年 9 月 13 日
Exploring Common CDISC ADaM Dataset Conformance Findings On-Demand Webinar Exploring Common CDISC ADaM Dataset Conformance Findings What you need to know when validating your CDISC ADAM datasets During the regulatory review…Certara2020 年 9 月 3 日
Arvinas Selects Certara’s D360 to Advance Speed and Efficiency of Discovery Research Case Study Arvinas 选择 Certara D360 来提高药物发现研究的速度和效率 In February 2020, we announced that Certara’s discovery research relationship with Arvinas had expanded to…Certara2020 年 8 月 21 日